- Home
- TRIB vs ACON Comparison
TRIB vs ACON Comparison
Compare TRIB & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- ACON
- Stock Information
- Founded
- TRIB 1992
- ACON 2008
- Country
- TRIB Ireland
- ACON United States
- Employees
- TRIB N/A
- ACON N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- TRIB Health Care
- ACON Technology
- Exchange
- TRIB Nasdaq
- ACON Nasdaq
- Market Cap
- TRIB 5.4M
- ACON 4.4M
- IPO Year
- TRIB N/A
- ACON 2022
- Fundamental
- Price
- TRIB $0.98
- ACON $7.75
- Analyst Decision
- TRIB
- ACON Buy
- Analyst Count
- TRIB 0
- ACON 2
- Target Price
- TRIB N/A
- ACON $22.00
- AVG Volume (30 Days)
- TRIB 120.8K
- ACON 404.5K
- Earning Date
- TRIB 11-14-2025
- ACON 11-13-2025
- Dividend Yield
- TRIB N/A
- ACON N/A
- EPS Growth
- TRIB N/A
- ACON N/A
- EPS
- TRIB N/A
- ACON N/A
- Revenue
- TRIB $61,555,000.00
- ACON $62,948.00
- Revenue This Year
- TRIB $13.51
- ACON $145.39
- Revenue Next Year
- TRIB $13.14
- ACON $145.45
- P/E Ratio
- TRIB N/A
- ACON N/A
- Revenue Growth
- TRIB 8.31
- ACON 16.68
- 52 Week Low
- TRIB $0.48
- ACON $6.20
- 52 Week High
- TRIB $3.44
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- TRIB 43.05
- ACON 46.99
- Support Level
- TRIB $0.88
- ACON $7.07
- Resistance Level
- TRIB $1.10
- ACON $7.89
- Average True Range (ATR)
- TRIB 0.07
- ACON 0.72
- MACD
- TRIB 0.00
- ACON -0.12
- Stochastic Oscillator
- TRIB 42.19
- ACON 13.71
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.